Global Hyperphosphatemia Therapeutics Market is valued at approximately USD 1.23 billion in 2022 and is anticipated to grow with a healthy growth rate of more than 8.2% over the forecast period ...
Key driver of the global onychomycosis market is the increasing prevalence of risk factors such as diabetes, aging population, weakened immune systems, and nail trauma.Westford, USA, Sept. 18, 2024 ...